Pharmacological modification of epidermal detoxification systems

Area of Science:

• Biochemistry
• Dermatology
• Toxicology

Background:

• The skin acts as a barrier between the body and the environment.
• Skin possesses cytochrome P-450-dependent enzymes involved in metabolizing endogenous and exogenous substances.
• These enzymes can either detoxify or enhance the toxicity of certain compounds, including environmental carcinogens.

Purpose of the Study:

• To investigate the potential of chemical inhibitors to control toxic responses in skin.
• To evaluate the efficacy of polyphenols and imidazoles in inhibiting epidermal carcinogen metabolism.

Main Methods:

• The study focused on the effects of specific polyphenols and imidazoles.
• Assays were conducted to measure inhibition of carcinogen metabolism and DNA binding.
• Carcinogenicity of polycyclic aromatic hydrocarbons (PAHs) was assessed.

Main Results:

• Polyphenols and imidazoles demonstrated potent inhibition of epidermal carcinogen metabolism.
• These agents significantly reduced the DNA binding of PAHs, such as benzo[a]pyrene (BP).
• Inhibition of carcinogen metabolism correlated with reduced carcinogenicity.

Conclusions:

• Chemical inhibitors, specifically certain polyphenols and imidazoles, can effectively block skin carcinogen metabolism.
• These compounds represent a promising strategy for preventing environmentally induced skin cancer.
• Targeting P-450-dependent enzyme activation in the skin offers a novel approach to cancer prevention.